Therdsak Prammananan Selected Research

Therdsak Prammananan Research Topics

12	Tuberculosis (Tuberculoses) 08/2019 - 04/2009
8	Extensively Drug-Resistant Tuberculosis 12/2020 - 02/2009
5	Infections 01/2021 - 09/2011
5	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 07/2018 - 02/2009
1	Persistent Infection 01/2016
1	Reinfection 01/2016
1	Noncommunicable Diseases 01/2015
1	Necrosis 06/2014

11	Pharmaceutical PreparationsIBA 12/2020 - 02/2009
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 03/2012
3	Kanamycin FDA Link 07/2018 - 06/2014
3	QuinolonesIBA 01/2018 - 06/2015
2	Amikacin (A.M.K)FDA LinkGeneric 07/2018 - 06/2014
2	resazurinIBA 01/2018 - 09/2017
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CholesterolIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2020
1	AminoglycosidesIBA 07/2018
1	Plant ExtractsIBA 09/2017
1	1'-acetoxychavicol acetateIBA 09/2017
1	DNA GyraseIBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	N 30IBA 01/2016
1	AT 61IBA 01/2016
1	Nucleic AcidsIBA 01/2015
1	VaccinesIBA 12/2014
1	Capreomycin (Capastat)FDA Link 06/2014
1	CytokinesIBA 06/2014
1	A-Form DNA (A-DNA)IBA 06/2014
1	Histidine (L-Histidine)FDA Link 12/2013
1	MacrolidesIBA 06/2013
1	Clarithromycin (Biaxin)FDA LinkGeneric 06/2013
1	Protein Synthesis InhibitorsIBA 06/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2011
1	pyrazinamide deamidaseIBA 08/2010
1	Linezolid (Zyvox)FDA Link 02/2009

2	Injections 07/2018 - 06/2014